About Careers MedBlog Contact us

Genetic Mutation That Opens Door in Combating Age-Related Diseases

by Dr. Trupti Shirole on December 17, 2016 at 10:22 AM
Font : A-A+

 Genetic Mutation That Opens Door in Combating Age-Related Diseases

The NADPH Oxidase complex attacks blood vessels, the heart lining, joints and the brain when placed under metabolic stress, causing most of the diseases of ageing. However it has another vital role in helping cells to 'talk' to each other, which means that humans need the complex in order to live.

Researchers at the University of Surrey, in collaboration with the Universities of Reading and Cologne, and the Royal Berkshire Hospital, have discovered that it is possible to stop the activation of this group of proteins (NADPH Oxidase) known to cause most of the diseases of ageing. This will potentially pave the way for the development of drugs to treat a range of age-related diseases.


The new research has found that the natural mutation SNP (single nucleotide polymorphism) protects against cardiovascular disease and also affects the activation of NADPH oxidase.

By identifying the molecular mechanism of an SNP, the research enables the design of drugs that will prevent the activation process in conditions of stress, without affecting the function of NADPH Oxidase in cell health. The researchers believe it will lead to the development of drugs to treat heart disease, diabetes, arthritis and dementia, and also fibrosis in the lungs.

In addition, the research has exciting implications for personalized medicine - a concept which is likely to change the face of healthcare in the future - as it will be possible, in theory, to give patients tailored doses of medicine depending on the SNP mutations they have.

Dr. Brendan Howlin, Director of Postgraduate Research at the University of Surrey, said: "This breakthrough could have a revolutionary impact on healthcare and individuals by tackling two of the key challenges in healthcare today: an ageing population and a growing requirement for personalized medicine. Since the initial research, we have developing a series of drugs that prevent the activation process, and are now working on bringing these drugs to market."

Source: Eurekalert

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Genetic Mutation That Opens Door in Combating Age-Related Diseases Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests